Home/Pipeline/Metabolic Disease Portfolio

Metabolic Disease Portfolio

Cardiovascular Disease, Obesity, Hypertension, Chronic Kidney Disease (CKD), Rare Disease

VariousArea of Expertise

Key Facts

Indication
Cardiovascular Disease, Obesity, Hypertension, Chronic Kidney Disease (CKD), Rare Disease
Phase
Various
Status
Area of Expertise
Company

About Clinical Research of Philadelphia

Clinical Research of Philadelphia (CRP) is a well-established, privately-held clinical research site that has been serving the Philadelphia community for nearly three decades. The company's mission is to advance medical research by connecting diverse patient populations with clinical trials, leveraging partnerships with over 50 community-based providers to access a potential patient pool of over 600,000. CRP has built a strong reputation for operational excellence, having enrolled over 10,000 participants since its founding, and focuses on therapeutic areas with high unmet need, including metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular risk, type 2 diabetes, and women's health conditions. Their patient-centric approach, technological infrastructure, and experienced team position them as a preferred site for pharmaceutical sponsors.

View full company profile